Nektar Therapeutics Cash Flow Quality Index
Nektar Therapeutics cash flow quality index. Nektar Therapeutics (NKTR) has a Cash Flow Quality Index of -6.36x as of December 2024. Operating cash flow of $-46.19 Million is below net income of $7.26 Million, suggesting accrual-heavy earnings not yet converted to cash. See Nektar Therapeutics leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Nektar Therapeutics (2018–2018)
Cash flow quality index of Nektar Therapeutics from 2018 to 2018. Historical Cash Flow Quality Index for Nektar Therapeutics across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore NKTR operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Nektar Therapeutics Cash Flow Quality Index by Year (2018–2018)
Nektar Therapeutics cash flow quality index by year from 2018 to 2018. Year-by-year earnings quality comparison for Nektar Therapeutics. For the full cash flow conversion analysis, see cash flow conversion of Nektar Therapeutics.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2018 | 1.05x | $718.21 Million | $681.31 Million | — |